Zakumumpa, Henry
Alinaitwe, Adolf
Kyomuhendo, Marjorie
Nakazibwe, Brenda
Funding for this research was provided by:
Consortium for Advanced Research Training in Africa (CARTA/2020/354.707A, CARTA/2020/354.707A, CARTA/2020/354.707A)
Article History
Received: 11 March 2024
Accepted: 12 August 2024
First Online: 28 August 2024
Declarations
:
: The clinical trial underpinning this study received formal ethical approval from a local Institutional Review Board (IRB) at Joint Clinical Research Centre in Kampala, Uganda and permission to conduct the clinical trial was secured from the Uganda National Council of Science and Technology. The clinical trial reported here is registered with the National Drug Authority (NDA) of Uganda.Study participants were approached individually at the study site and informed of the present study’s objectives and invited to participate voluntarily with indication that it was their prerogative to withdraw at any time. Each of the participants who agreed to participate in the study signed a written informed consent. The study was guided by the treaty of Helsinki regarding human subjects.
: Not applicable.
: The authors declare no competing interests.